Cargando…
Structural analysis of cannabinoids against EGFR-TK leads a novel target against EGFR-driven cell lines
Epidermal growth factor receptor (EGFR) is a member of the ErbB family of proteins and are involved in downstream signal transduction, plays prominent roles in cell growth regulation, proliferation, and the differentiation of many cell types. They are correlated with the stage and severity of cancer...
Autores principales: | Lamtha, Thomanai, Tabtimmai, Lueacha, Songtawee, Napat, Tansakul, Natthasit, Choowongkomon, Kiattawee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780064/ https://www.ncbi.nlm.nih.gov/pubmed/36568260 http://dx.doi.org/10.1016/j.crphar.2022.100132 |
Ejemplares similares
-
A novel nanobody as therapeutics target for EGFR-positive colorectal cancer therapy: exploring the effects of the nanobody on SW480 cells using proteomics approach
por: Lamtha, Thomanai, et al.
Publicado: (2022) -
The Effect of the EGFR - Targeting Compound 3-[(4-Phenylpyrimidin-2-yl) Amino] Benzene-1-Sulfonamide (13f) against Cholangiocarcinoma Cell Lines
por: Samatiwat, Papavee, et al.
Publicado: (2021) -
Receptor-Based Virtual Screening of EGFR Kinase Inhibitors from the NCI Diversity Database
por: Choowongkomon, Kiattawee, et al.
Publicado: (2010) -
Identification of Vinyl Sulfone Derivatives as EGFR Tyrosine Kinase Inhibitor: In Vitro and In Silico Studies
por: Aiebchun, Thitinan, et al.
Publicado: (2021) -
Understanding the molecular basis of EGFR kinase domain/MIG-6 peptide recognition complex using computational analyses
por: Moonrin, Ninnutt, et al.
Publicado: (2015)